Exact Mass: 365.0647826

Exact Mass Matches: 365.0647826

Found 224 metabolites which its exact mass value is equals to given mass value 365.0647826, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Amoxicillin

(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C16H19N3O5S (365.10453640000003)

Amoxicillin (International Nonproprietary Name), or amoxycillin (British Approved Name), is a moderate-spectrum, bacteriolytic, -lactam antibiotic used to treat bacterial infections caused by susceptible microorganisms. It is a broad-spectrum semisynthetic antibiotic similar to ampicillin except that its resistance to gastric acid permits higher serum levels with oral administration (PubChem). Amoxicillin is active against a wide range of Gram-positive and a limited range of Gram-negative organisms. It is susceptible to degradation by beta-lactamase-producing bacteria, and so may be given with clavulanic acid to increase its susceptibility. The incidence of beta-lactamase-producing resistant organisms, including E. coli, appears to be increasing. Amoxicillin binds to penicillin-binding protein 1A (PBP-1A) located inside the bacterial cell wall. Penicillins acylate the penicillin-sensitive transpeptidase C-terminal domain by opening the lactam ring. This inactivation of the enzyme prevents the formation of a cross-link of two linear peptidoglycan strands, inhibiting the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that amoxicillin interferes with an autolysin inhibitor. Amoxicillin is usually the drug of choice within the class because it is better absorbed, following oral administration, than other -lactam antibiotics. Amoxicillin in trihydrate form is available as capsules, chewable and dispersible tablets, syrup and pediatric suspension for oral use, and as the sodium salt for intravenous administration. It is one of the most common antibiotics prescribed for children, and the liquid forms are helpful in cases where the patient might find it difficult to take tablets or capsules. It has three ionizable groups. Amoxicillin as a once-daily dosing form (Moxatag) was approved by the American FDA in January 2008. Amoxicillin is one of the semi-synthetic penicillins discovered by Beecham scientists. The patent for amoxicillin has expired, thus amoxicillin is marketed under many trade names, including Actimoxi, Alphamox, AMK, Amoksibos, Amoxiclav Sandoz, Amoxidal, Amoxil, Amoxin, Amoksiklav, Amoxibiotic, Amoxicilina, Apo-Amoxi, Augmentin, Bactox, Betalaktam, Cilamox, Curam, Dedoxil, Dispermox, Duomox, E-Mox (250mg and 500 mg), Enhancin, Gimalxina, Geramox, Hiconcil, Isimoxin, Klavox, Lamoxy, Moxatag, Moxilen, Moxypen, Moxyvit, Nobactam, Novamoxin, Ospamox, Panklav, Pamoxicillin, Panamox, Polymox, Samthongcillin, Clamoxyl, Senox, Sinacilin, Trimox, Tolodina, Wymox, Yucla, Zerrsox, and Zimox. Amoxicillin is found in milk and milk products. It is a potential contaminant in cows milk arising from its veterinary use. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Benzoylprop-ethyl

ethyl 2-[N-(3,4-dichlorophenyl)-1-phenylformamido]propanoate

C18H17Cl2NO3 (365.05854320000003)

6-Methylpretetramide

1,3,10,11,12-Pentahydroxy-6-methyltetracene-2-carboxamide

C20H15NO6 (365.08993300000003)

A member of the class of pretetramides in which the only additional substituent is a methyl group at position 6.

Cefroxadine

C16H19N3O5S (365.10453640000003)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D01528

Furo(3,4-b)pyridine-3-carboxylic acid, 1,4,5,7-tetrahydro-4-(2-(difluoromethoxy)phenyl)-2-methyl-5-oxo-, ethyl ester

C18H17F2NO5 (365.10747360000005)

D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents > D002120 - Calcium Channel Agonists D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

2-S-glutathionyl acetate

(2S)-2-Amino-4-{[(1R)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(carboxymethyl)sulphanyl]ethyl]-C-hydroxycarbonimidoyl}butanoic acid

C12H19N3O8S (365.0892814)

2-S-glutathionyl acetate is also known as S-(Carboxymethyl)glutathione. 2-S-glutathionyl acetate is considered to be slightly soluble (in water) and acidic

Cephalexin monohydrate

C16H19N3O5S (365.10453640000003)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

metolazone

Metolazone (Zaroxolyn)

C16H16ClN3O3S (365.0600856)

indapamide

Indapamide (Lozol)

C16H16ClN3O3S (365.0600856)

C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain D045283 - Natriuretic Agents > D004232 - Diuretics > D049993 - Sodium Chloride Symporter Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators CONFIDENCE standard compound; INTERNAL_ID 687; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3822; ORIGINAL_PRECURSOR_SCAN_NO 3820 CONFIDENCE standard compound; INTERNAL_ID 687; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3835; ORIGINAL_PRECURSOR_SCAN_NO 3834 CONFIDENCE standard compound; INTERNAL_ID 687; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3799; ORIGINAL_PRECURSOR_SCAN_NO 3798 CONFIDENCE standard compound; INTERNAL_ID 687; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3832; ORIGINAL_PRECURSOR_SCAN_NO 3829 CONFIDENCE standard compound; INTERNAL_ID 687; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3815; ORIGINAL_PRECURSOR_SCAN_NO 3812 CONFIDENCE standard compound; INTERNAL_ID 687; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3819; ORIGINAL_PRECURSOR_SCAN_NO 3817 CONFIDENCE standard compound; INTERNAL_ID 687; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7807; ORIGINAL_PRECURSOR_SCAN_NO 7802 CONFIDENCE standard compound; INTERNAL_ID 687; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7842; ORIGINAL_PRECURSOR_SCAN_NO 7839 CONFIDENCE standard compound; INTERNAL_ID 687; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7849; ORIGINAL_PRECURSOR_SCAN_NO 7846 CONFIDENCE standard compound; INTERNAL_ID 687; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7871; ORIGINAL_PRECURSOR_SCAN_NO 7868 CONFIDENCE standard compound; INTERNAL_ID 687; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7902; ORIGINAL_PRECURSOR_SCAN_NO 7900 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3686 CONFIDENCE standard compound; INTERNAL_ID 1111

Indapamide

4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)-3-sulfamoylbenzamide

C16H16ClN3O3S (365.0600856)

Indapamide is only found in individuals that have used or taken this drug. It is a benzamide-sulfonamide-indole. It is called a thiazide-like diuretic but structure is different enough (lacking the thiazo-ring) so it is not clear that the mechanism is comparable. [PubChem]Indapamide blocks the slow component of delayed rectifier potassium current (IKs) without altering the rapid component (IKr) or the inward rectifier current. Specifically it blocks or antagonizes the action the proteins KCNQ1 and KCNE1. Indapamide is also thought to stimulate the synthesis of the vasodilatory hypotensive prostaglandin PGE2. C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain D045283 - Natriuretic Agents > D004232 - Diuretics > D049993 - Sodium Chloride Symporter Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators

Metolazone

7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulphonamide

C16H16ClN3O3S (365.0600856)

Metolazone is only found in individuals that have used or taken this drug. It is a quinazoline-sulfonamide that is considered a thiazide-like diuretic which is long-acting so useful in chronic renal failure. It also tends to lower blood pressure and increase potassium loss. [PubChem]The actions of metolazone result from interference with the renal tubular mechanism of electrolyte reabsorption. Metolazone acts primarily to inhibit sodium reabsorption at the cortical diluting site and to a lesser extent in the proximal convoluted tubule. Sodium and chloride ions are excreted in approximately equivalent amounts. The increased delivery of sodium to the distal tubular exchange site results in increased potassium excretion. Metolazone does not inhibit carbonic anhydrase. The antihypertensive mechanism of action of metolazone is not fully understood but is presumed to be related to its saluretic and diuretic properties. C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain D045283 - Natriuretic Agents > D004232 - Diuretics > D049993 - Sodium Chloride Symporter Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators

4beta-(2-Aminoethylthio)catechin

4-[(2-Aminoethyl)sulphanyl]-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol

C17H19NO6S (365.0933034)

4beta-(2-Aminoethylthio)epicatechin is found in alcoholic beverages. 4beta-(2-Aminoethylthio)epicatechin is a constituent of Vitis vinifera (wine grape). Constituent of Vitis vinifera (wine grape). 4beta-(2-Aminoethylthio)catechin is found in alcoholic beverages and fruits.

Fludarabine

{[(2R,3S,4S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H13FN5O7P (365.05366100000003)

Fludarabine is only found in individuals that have used or taken this drug. Fludarabine (marketed as fludarabine phosphate under the trade name Fludara) is a chemotherapy drug used in the treatment of hematological malignancies. [Wikipedia]Fludarabine phosphate is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP. This metabolite appears to act by inhibiting DNA polymerase alpha, ribonucleotide reductase and DNA primase, thus inhibiting DNA synthesis. The mechanism of action of this antimetabolite is not completely characterized and may be multi-faceted. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2150 - Ribonucleotide Reductase Inhibitor D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Fludarabine (phosphate) is an analogue of adenosine and deoxyadenosine, which is able to compete with dATP for incorporation into DNA and inhibit DNA synthesis.

Nifursol

2-Hydroxy-3,5-dinitro-N-[(1Z)-(5-nitrofuran-2-yl)methylidene]benzene-1-carbohydrazonate

C12H7N5O9 (365.0243772)

Veterinary antiprotozoal, especially for poultr

Hydromorphone-3-sulphate

{4-methyl-14-oxo-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-trien-10-yl}oxidanesulfonic acid

C17H19NO6S (365.0933034)

Hydromorphone-3-sulphate is a metabolite of hydromorphone. Hydromorphone, a more common synonym for dihydromorphinone, commonly a hydrochloride (brand names Palladone, Dilaudid, and numerous others) is a very potent centrally acting analgesic drug of the opioid class. It is a derivative of morphine, to be specific, a hydrogenated ketone thereof and, therefore, a semi-synthetic drug. It is, in medical terms, an opioid analgesic and, in legal terms, a narcotic. (Wikipedia)

UK-121,265

4-[(2S,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl]-5-fluoropyrimidin-1-ium-1-olate

C16H14F3N5O2 (365.109954)

UK-121,265 is a metabolite of voriconazole. Voriconazole is a triazole antifungal medication that is generally used to treat serious, invasive fungal infections. These are generally seen in patients who are immunocompromised, and include invasive candidiasis, invasive aspergillosis, and certain emerging fungal infections. (Wikipedia)

4-Hydroxyvoriconazole

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butane-1,2-diol

C16H14F3N5O2 (365.109954)

4-Hydroxyvoriconazole is a metabolite of voriconazole. Voriconazole is a triazole antifungal medication that is generally used to treat serious, invasive fungal infections. These are generally seen in patients who are immunocompromised, and include invasive candidiasis, invasive aspergillosis, and certain emerging fungal infections. (Wikipedia)

4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-

C16H19N3O5S (365.10453640000003)

Potential contaminant in cows milk arising from its veterinary use

Fludara

{[5-(6-amino-2-fluoro-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H13FN5O7P (365.05366100000003)

D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents

2-Hydroxy-4-(2-(tosyloxy)acetamido)benzoic acid

2-hydroxy-4-{2-[(4-methylbenzenesulfonyl)oxy]acetamido}benzoic acid

C16H15NO7S (365.05692)

4-Carbamothioylphenyl 2-(6-methoxynaphthalen-2-yl)propanoate

2-(6-Methoxy-napthalen-2-yl)-propionic acid 4-thiocarbamoyl-phenyl ester

C21H19NO3S (365.1085584000001)

cefroxadine

7-{[2-amino-2-(cyclohexa-1,4-dien-1-yl)-1-hydroxyethylidene]amino}-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C16H19N3O5S (365.10453640000003)

Same as: D01528

Clinafloxacin

7-(3-aminopyrrolidin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C17H17ClFN3O3 (365.0942414)

D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

Luxabendazole

N-{6-[(4-fluorobenzenesulphonyl)oxy]-1H-1,3-benzodiazol-2-yl}methoxycarboximidic acid

C15H12FN3O5S (365.0481674)

Morphine 3-Sulfate

{14-hydroxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,15-tetraen-10-yl}oxidanesulfonic acid

C17H19NO6S (365.0933034)

Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl-, (5alpha,6alpha)-, 3-(hydrogen sulfate)

{10-hydroxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,15-tetraen-14-yl}oxidanesulfonic acid

C17H19NO6S (365.0933034)

p38 MAP Kinase Inhibitor

2-(4-chlorophenyl)-4-(4-fluorophenyl)-5-(pyridin-4-yl)-2,3-dihydro-1H-pyrazol-3-one

C20H13ClFN3O (365.07311300000003)

4,5-Dioxodehydrocrebanine

C20H15NO6 (365.08993300000003)

Eudistomidin C

C15H16BrN3OS (365.01973860000004)

Chlorodesnkolbisine

6-(2-Hydroxy-3-chloroprenyloxy)-4,7-dimethoxyfuroquinoline

C18H20ClNO5 (365.1029940000001)

Formamide, N-(6-(6-hydroxy-1,3-benzodioxol-5-yl)naphtho(2,3-d)-1,3-dioxol-5-yl)-N-methyl-

C20H15NO6 (365.08993300000003)

Taveuniamide F

C17H26Cl3NO (365.10798760000006)

Turkiyenine

C20H15NO6 (365.08993300000003)

Corydione

4,5-Dioxodehydronantenine

C20H15NO6 (365.08993300000003)

Cyto3A7

C20H13Cl2N3 (365.0486478)

Ethyl 2-({2-cyano-3-[(ethoxycarbonyl)amino]-3-oxoprop-1-enyl}amino)-4,5-dimethylthiophene-3-carboxylate

C16H19N3O5S (365.10453640000003)

UNII-KHR1SJ9L0Y

C17H20BrNO3 (365.0626470000001)

Maybridge3_003568

C16H15NO5S2 (365.039162)

MCULE-7947653224

C16H16ClN3O3S (365.0600856)

Maybridge4_000003

C17H14F3N3O3 (365.09872100000007)

3-(1,3-benzothiazol-2-yl)-6-ethyl-4-oxo-4H-chromen-7-yl acetate

C20H15NO4S (365.0721750000001)

Maybridge3_000714

C20H16ClN3O2 (365.0930986)

MMV688798

C21H19NO3S (365.1085584000001)

7-oxobaicaline|Oxobaicaline

C20H15NO6 (365.08993300000003)

WF 16775 A1

C15H21Cl2NO5 (365.07967160000004)

Griseolic acid C

C14H15N5O7 (365.097144)

4,8-Dimethoxy-7-(2-hydroxy-3-methyl-3-chlorobutyloxy)furo[2,3-b]quinoline

C18H20ClNO5 (365.1029940000001)

erysopine 15-O-sulfate

C17H19NO6S (365.0933034)

2-amino-5,8,5-trihydroxy-2,3,4-pentahydro-[4,3]-binaphthalene-1,1,4-trione

C20H15NO6 (365.08993300000003)

C20H15NO6

C20H15NO6 (365.08993300000003)

Oxophoebine

C20H15NO6 (365.08993300000003)

6-(5-Acetyl-1,3-benzodioxole-4-ylmethyl)-1,3-dioxolo[4,5-g]isoquinoline-5(6H)-one

C20H15NO6 (365.08993300000003)

YK-4-279

4,7-dichloro-1,3-dihydro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-2H-indole-2-one

C17H13Cl2NO4 (365.02215980000005)

Asp Cys Glu

C12H19N3O8S (365.0892814)

Glu Cys Asp

C12H19N3O8S (365.0892814)

Cys Asp Glu

C12H19N3O8S (365.0892814)

4H-Benzo(de)(1,3)benzodioxolo(5,6-g)quinoline-4,5(6H)-dione,1,2-dimethoxy-6-methyl-

C20H15NO6 (365.08993300000003)

Amoxicillin

Amoxicilin - Dark Web Drugs

C16H19N3O5S (365.10453640000003)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-(4-hydroxyphenyl)acetamido group. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Constituent of Panax notoginseng (sanchi). Notoginsenoside J is found in tea. MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; LSQZJLSUYDQPKJ-NJBDSQKTSA-N_Amoxicillin_STSL_0201_Amoxicillin Trihydrate_2000fmol_180831_S2_L02M02_41; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. CONFIDENCE standard compound; EAWAG_UCHEM_ID 3083

Amoxicillin (Amoxycillin)

C16H19N3O5S (365.10453640000003)

Amoxicillin Trihydrate

C16H19N3O5S (365.10453640000003)

Morphine 3-Sulfate

C17H19NO6S (365.0933034)

Morphine 6-sulfate

C17H19NO6S (365.0933034)

Cys Glu Asp

C12H19N3O8S1 (365.0892814)

Glu Cys Asp

C12H19N3O8S1 (365.0892814)

Cys Asp Glu

C12H19N3O8S1 (365.0892814)

Asp Glu Cys

C12H19N3O8S1 (365.0892814)

Asp Cys Glu

C12H19N3O8S1 (365.0892814)

Glu Asp Cys

C12H19N3O8S1 (365.0892814)

H 152/77

C17H13Cl2NO4 (365.02215980000005)

Fludarabine phosphate

C10H13FN5O7P (365.05366100000003)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2150 - Ribonucleotide Reductase Inhibitor D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Fludarabine (phosphate) is an analogue of adenosine and deoxyadenosine, which is able to compete with dATP for incorporation into DNA and inhibit DNA synthesis.

Nifursol

2-Hydroxy-3,5-dinitrobenzoic acid [(5-nitro-2-furanyl)methylene]hydrazide, 9ci

C12H7N5O9 (365.0243772)

C254 - Anti-Infective Agent > C258 - Antibiotic

4b-(2-Aminoethylthio)catechin

4-[(2-aminoethyl)sulfanyl]-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol

C17H19NO6S (365.0933034)

1-BOC-2-CHLORO-3-(2-ETHOXYCARBONYL-ACETYL)-INDOLE

C18H20ClNO5 (365.1029940000001)

tert-Butyl 4-(4-bromo-2-cyanophenyl)piperazine-1-carboxylate

C16H20BrN3O2 (365.07388000000003)

Zidapamide

4-chloro-N-(1-methyl-1,3-dihydroisoindol-2-yl)-3-sulfamoylbenzamide

C16H16ClN3O3S (365.0600856)

C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic

2-acetamido-2-deoxy-alpha-D-glucopyranosyl chloride 3,4,6-triacetate

C14H20ClNO8 (365.087739)

L-Amoxicillin

Amoxicillin, L-

C16H19N3O5S (365.10453640000003)

S-1-Pyrrolidinecarboxylic acid, 2-(6-bromo-1H-benzimidazol-2-yl)-, 1,1-dimethyleth

C16H20BrN3O2 (365.07388000000003)

CGP 53353

5,6-Bis[(4-fluorophenyl)amino]-1H-isoindole-1,3(2H)-dione

C20H13F2N3O2 (365.09757820000004)

D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

4-[BIS(4-FLUOROPHENYL)METHYLENE]PIPERIDINE HYDROBROMIDE

C18H18BrF2N (365.05905920000004)

Naphthaloximidodiethyl thiophosphate

C16H16NO5PS (365.0486776)

1-(4-bromo-2-phenylmethoxyphenyl)-N-phenylmethanimine

C20H16BrNO (365.0415186)

Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro- (6CI,7CI,8CI,9CI)

C18H11N3O4S (365.04702460000004)

3-BROMO-N-(3,3-DIETHOXY-PROPYL)-BENZENESULFONAMIDE

C13H20BrNO4S (365.0296340000001)

Bis(4-nitrophenyl) phosphorazidate

C12H8N5O7P (365.01613480000003)

5-(6-Bromonaphthalen-2-yl)-2,2-dimethyl-5-nitro-1,3-dioxane

C16H16BrNO4 (365.02626360000005)

(+)-Biotin-ONP

C16H19N3O5S (365.10453640000003)

3-[(4-Chlorophenyl)thio]-1-(diphenylmethyl)azetidine

C22H20ClNS (365.1004910000001)

(-)-ADENOSIN-3-PHOSPHORSAEURE HYDRAT 99

C10H16N5O8P (365.0736466)

3-ETHYL-2-METHYL-5-PHENYL-BENZOOXAZOL-3-IUM IODIDE

C16H16INO (365.0276596)

Luxabendazole

Luxalbendazole

C15H12FN3O5S (365.0481674)

C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

N-(10-Bromodecyl)phthalimide

C18H24BrNO2 (365.0990304)

Benzyl (1R,2S)-3-chloro-2-hydroxy-1-(phenylthiomethyl)propylcarbamate

C18H20ClNO3S (365.0852360000001)

L-Cysteine,N-[(4-methylphenyl)sulfonyl]-S-(phenylmethyl)-

C17H19NO4S2 (365.0755454)

1(2H)-Pyridinecarboxylic acid, 3,6-dihydro-4-[[(trifluoromethyl)sulfonyl]oxy]-, phenylmethyl ester

C14H14F3NO5S (365.054475)

N-((5-(4-chloroquinazolin-6-yl)furan-2-yl)Methyl)-2-(Methylsulfonyl)ethanamine

C16H16ClN3O3S (365.0600856)

Atpenin A5

C15H21Cl2NO5 (365.07967160000004)

(R)-(-)-GLYCIDYLMETHYLETHER

C19H15N3O5 (365.10116600000003)

4-methoxyphenylazoformyl-phe potassium salt

C17H16KN3O4 (365.07778360000003)

Benzenesulfonic acid,3-[2-[4-(diethylamino)-2-hydroxyphenyl]diazenyl]-4-hydroxy-

C16H19N3O5S (365.10453640000003)

(2,3,4,5,6-pentafluorophenyl) 6-phenylpyridine-3-carboxylate

C18H8F5NO2 (365.0475168)

C.I.Acid Brown 4

C16H12N3NaO4S (365.04461920000006)

2-(2-Hydroxy-4-benzoyloxyphenyl)-5-chlorobenzotriazole

C19H12ClN3O3 (365.0567152)

Alkofanone

C21H19NO3S (365.1085584000001)

(2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2,3-butanediol methanesulfonate

C13H17F2N3O5S (365.0856936)

Cefuroxime Sodium EP Impurity C

C15H15N3O6S (365.06815300000005)

6-Chloro-3-indolyl β-D-glucuronide sodium salt

C14H13ClNNaO7 (365.02782179999997)

POLY(4-VINYLPHENOL) BROMINATED

C16H19N3O5S (365.10453640000003)

(S)-(+)-DBD-PY-NCS

C19H15N3O5 (365.10116600000003)

Itazigrel

C18H14F3NO2S (365.06973000000005)

C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent C471 - Enzyme Inhibitor

Adenosine 5-monophosphate monohydrate

C10H16N5O8P (365.0736466)

Adenosine 5'-monophosphate monohydrate is an adenosine A1 receptor agonist. Adenosine 5'-monophosphate monohydrate has significant antiviral activity against HSV-1 and HSV-2. Adenosine 5'-monophosphate monohydrate is an adenosine A1 receptor agonist. Adenosine 5'-monophosphate monohydrate has significant antiviral activity against HSV-1 and HSV-2. Adenosine 5'-monophosphate monohydrate is an adenosine A1 receptor agonist. Adenosine 5'-monophosphate monohydrate has significant antiviral activity against HSV-1 and HSV-2. Adenosine 5'-monophosphate monohydrate is an adenosine A1 receptor agonist. Adenosine 5'-monophosphate monohydrate has significant antiviral activity against HSV-1 and HSV-2.

2,2:6,2-Terpyridine-4,4,4-tricarboxylic acid

C18H11N3O6 (365.0647826)

O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate

C11H16N3O7PS (365.0446556)

(S)-Indapamide

C16H16ClN3O3S (365.0600856)

Foslinanib

C16H13FNO6P (365.04645)

C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor

Leteprinim potassium

C15H12KN5O4 (365.0526332)

C26170 - Protective Agent > C1509 - Neuroprotective Agent

Voriconazole N-Oxide

C16H14F3N5O2 (365.109954)

p38 MAP Kinase Inhibitor

C20H13ClFN3O (365.07311300000003)

Pyriofenone

C18H20ClNO5 (365.1029940000001)

Fenoxasulfone

C14H17Cl2NO4S (365.0255302000001)

Diamthazole dihydrochloride

C15H25Cl2N3OS (365.10953000000006)

3,3-Diethylthiacarbocyanine

C21H21N2S2+ (365.1146086)

D004396 - Coloring Agents > D002232 - Carbocyanines

N-[4-(2,4-dichlorophenoxy)-6-(trifluoromethyl)-2-pyrimidinyl]-N-isopropylamine

C14H12Cl2F3N3O (365.03094780000004)

4-(4-Methylphenyl)sulfonyl-3-phenyl-2,3-dihydro-1,4-benzoxazine

C21H19NO3S (365.1085584000001)

N-(2-furanylmethyl)-2-[(3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)thio]acetamide

C18H15N5O2S (365.094641)

5-Bromo-1H-indol-3-yl decanoate

C18H24BrNO2 (365.0990304)

2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide

C21H16ClNO3 (365.0818656)

5-Monophosphate-9-beta-D-ribofuranosyl xanthine

C10H14N4O9P+ (365.04983840000006)

N-benzyl-2-methylsulfonyl-N-phenylbenzamide

C21H19NO3S (365.1085584000001)

(2S,5R,6R)-6-[[(2R)-2-azaniumyl-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C16H19N3O5S (365.10453640000003)

8-Carboxy-2,4,6,9-tetrahydroxy-7-methyltetracen-5-olate

C20H13O7- (365.0661248)

[(1S)-2-[2-[(2R)-2-amino-2-carboxyethyl]selanyl-1H-imidazol-5-yl]-1-carboxyethyl]-trimethylazanium

C12H21N4O4Se+ (365.0727936)

acetamidomethyl-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]oxyphosphinic acid

C8H17NO11P2 (365.02768319999996)

3-ethyl-2-[3-(3-ethyl-1,3-benzothiazol-2(3H)-ylidene)prop-1-en-1-yl]-1,3-benzothiazol-3-ium

C21H21N2S2+ (365.1146086)

1-[4-(4-Bromophenyl)-2-thiazolyl]-4-piperidinecarboxamide

C15H16BrN3OS (365.01973860000004)

4-(4-chlorophenyl)-1-(2-methoxyethyl)-4H-pyridine-3,5-dicarboxylic acid dimethyl ester

C18H20ClNO5 (365.1029940000001)

4-Cyanobenzoic acid [4-oxo-6-[(2-pyrimidinylthio)methyl]-3-pyranyl] ester

C18H11N3O4S (365.04702460000004)

N-[3-(1,3-benzothiazol-2-yl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl]-2,2-difluoroacetamide

C16H13F2N3OS2 (365.0468072)

Amoxicillin Diketopiperazine

C16H19N3O5S (365.10453640000003)

3-methyl-1-[2-(2H-tetrazol-5-yl)ethyl]-4,6-bis(trifluoromethyl)pyrazolo[3,4-b]pyridine

C12H9F6N7 (365.0823586)

tetracenomycin F1(1-)

C20H13O7- (365.0661248)

A hydroxy monocarboxylic acid anion that is the conjugate base of tetracenomycin F1, obtained by deprotonation of the carboxy group.

2-(2-bromo-4-tert-butylphenoxy)-N-(2-furanylmethyl)acetamide

C17H20BrNO3 (365.0626470000001)

6-(2-chlorophenyl)-N-[(4-methyl-2-thiophenyl)methyl]-4-quinazolinamine

C20H16ClN3S (365.07534060000006)

N-(2-furanylmethyl)-2-(4-oxo-6-phenyl-3-thieno[2,3-d]pyrimidinyl)acetamide

C19H15N3O3S (365.0834080000001)

3-[[[1-(2,4-Dimethylphenyl)-5-tetrazolyl]thio]methyl]-1,2,3-benzotriazin-4-one

C17H15N7OS (365.10587400000003)

N-[5-fluoro-2-(3-oxo-4H-quinoxalin-2-yl)phenyl]-2-thiophenecarboxamide

C19H12FN3O2S (365.06342240000004)

4-(2,3-Dihydro-1,4-benzodioxin-3-ylmethylamino)-3-nitrobenzenesulfonamide

C15H15N3O6S (365.06815300000005)

N(4)-acetylcytidine 5-monophosphate

C11H16N3O9P (365.0624136)

5-(3,4-Dimethoxyphenyl)-2-phenyl-4-thieno[2,3-d][1,3]oxazinone

C20H15NO4S (365.0721750000001)

5-(2,5-dichlorophenyl)-N-(2-propyl-5-tetrazolyl)-2-furancarboxamide

C15H13Cl2N5O2 (365.0446258)

1-[(E)-[3-[(2-chloro-6-fluorophenyl)methoxy]phenyl]methylideneamino]-3-ethylthiourea

C17H17ClFN3OS (365.07648340000003)

2-Phenylbutanoic acid [2-(3,5-dichloroanilino)-2-oxoethyl] ester

C18H17Cl2NO3 (365.05854320000003)

5-ethyl-N-[[2-(3-pyridinyl)-4-thiazolyl]methyl]-2-thiophenesulfonamide

C15H15N3O2S3 (365.032637)

2-(4-Bromo-3-methylphenyl)-4-[(3-methoxypropylamino)methylidene]-5-methyl-3-pyrazolone

C16H20BrN3O2 (365.07388000000003)

ethyl 2-{[(1E)-(4,6-dioxo-2-thioxohexahydropyrimidin-5-yl)methylene]amino}-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate

C15H15N3O4S2 (365.050395)

6-(3-chlorophenyl)-N-[(4-methyl-2-thiophenyl)methyl]-4-quinazolinamine

C20H16ClN3S (365.07534060000006)

Asp-Cys-Glu

C12H19N3O8S (365.0892814)

Glu-Cys-Asp

C12H19N3O8S (365.0892814)

2-[6-(4-Chloro-phenyl)-1-methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetamide

C20H16ClN3O2 (365.0930986)

2-(4-(Tert-butyl)benzamido)-4,5-dichlorobenzoic acid

C18H17Cl2NO3 (365.05854320000003)

4beta-(2-Aminoethylthio)catechin

C17H19NO6S (365.0933034)

1-(2-Furanylmethyl)-4-[oxo(thiophen-2-yl)methyl]-5-phenylpyrrolidine-2,3-dione

C20H15NO4S (365.0721750000001)

Asp-Glu-Cys

C12H19N3O8S (365.0892814)

Cys-Asp-Glu

C12H19N3O8S (365.0892814)

Cys-Glu-Asp

C12H19N3O8S (365.0892814)

Glu-Asp-Cys

C12H19N3O8S (365.0892814)

L-cystine mono-2-naphthylamide

C16H19N3O3S2 (365.0867784)

N-[(Z)-1-(2-hydroxyphenyl)ethylideneamino]-3-(3-nitrophenyl)-1H-pyrazole-5-carboxamide

C18H15N5O4 (365.11239900000004)

Methyl 2-O-chlorobenzoyl-4-chloro-N-methyloxalonilate

C17H13Cl2NO4 (365.02215980000005)

Benzoylprop-ethyl

C18H17Cl2NO3 (365.05854320000003)

1,3,10,11,12-Pentahydroxy-6-methyltetracene-2-carboxamide

C20H15NO6 (365.08993300000003)

Clinafloxacin

C17H17ClFN3O3 (365.0942414)

2-S-glutathionyl acetate

S-(Carboxymethyl)glutathione

C12H19N3O8S (365.0892814)

CGP 28 392

CGP 28-392

C18H17F2NO5 (365.10747360000005)

S3I-201

2-Hydroxy-4-(2-(tosyloxy)acetamido)benzoic acid

C16H15NO7S (365.05692)

4-Hydroxyvoriconazole

C16H14F3N5O2 (365.109954)

Hydromorphone-3-sulphate

C17H19NO6S (365.0933034)

Methylpretetramide

C20H15NO6 (365.08993300000003)

Afizagabar

C19H12FN3O2S (365.06342240000004)

Afizagabar (S44819) is a first-in-class, competitive, and selective antagonist at the GABA-binding site of the α5-GABAAR, with an IC50 of 585 nM for α5β2γ2 and a Ki of 66 nM for α5β3γ2. Afizagabar enhances hippocampal synaptic plasticity and exhibits pro-cognitive efficacy[1].

GYKI 52466 (dihydrochloride)

C17H17Cl2N3O2 (365.06977620000004)

GYKI 52466 dihydrochloride is an orally active, highly selective and noncompetitive AMPA/kainate receptor antagonist with the IC50 values of 7.5 and 11μM, respectively. GYKI 52466 dihydrochloride has good blood brain barrier permeability and anticonvulsant effect. GYKI 52466 dihydrochloride can be used in Parkinson's disease research[1][2].

HIF-2α-IN-2

C17H13F2NO4S (365.05333220000006)

HIF-2α-IN-2 is a hypoxia-inducible factors (HIF-2α) inhibitor extracted from patent WO2015035223A1, Compound 232, has an IC50 of 16 nM in scintillation proximity assay (SPA)[1].

17,18,19-trimethoxy-5,7-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁸.0¹⁶,²⁰]icosa-1(19),2,4(8),9,12(20),13,15,17-octaen-11-one

C20H15NO6 (365.08993300000003)

5-(6-aminopurin-9-yl)-2-(carboxymethyl)-6-hydroxy-tetrahydro-3h-furo[3,2-b]furan-2-carboxylic acid

C14H15N5O7 (365.097144)

7,16,17-trimethoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,10,12(20),14(19),15,17-octaen-13-one

C20H15NO6 (365.08993300000003)

7-oxobaicaline

C20H15NO6 (365.08993300000003)

{"Ingredient_id": "HBIN013428","Ingredient_name": "7-oxobaicaline","Alias": "NA","Ingredient_formula": "C20H15NO6","Ingredient_Smile": "NA","Ingredient_weight": "365.34","OB_score": "36.09358329","CAS_id": "105418-66-4","SymMap_id": "SMIT10028","TCMID_id": "NA","TCMSP_id": "MOL008805","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}